Business & Industry
Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems
Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy its Claude platform across global operations. This initiative moves beyond standard conversational tools, aiming to embed agentic AI capabilities directly into core workflows, including research, clinical...
Business & Industry
MHRA Launches Public Consultation on New Rare Disease Therapies Framework to Strengthen UK’s Global Position
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on a proposed Rare Disease Therapies Framework a regulatory proposal that would introduce a new development and authorisation pathway for therapies targeting rare diseases in the...
Business & Industry
QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery
QIAGEN's Digital Insights bioinformatics division is set to integrate NVIDIA's accelerated computing infrastructure and the BioNeMo platform to strengthen AI-driven drug discovery capabilities for pharmaceutical and biotechnology researchers. The collaboration aims to make AI more actionable in research settings...
Clinical Trials
Algeria and Hungary Enhance Pharmaceutical Industry Collaboration via R&D and Clinical Trials
In a strategic move to bolster the national pharmaceutical industry, the Algerian Minister of Pharmaceutical Industry, Mr. Wassim Kouidri, convened with the Ambassador of the Republic of Hungary, Mr. Gábor Levente Szarka, this Sunday in Algiers. The high-level discussions...
Business & Industry
AstraZeneca’s Baxfendy Wins FDA Approval for Uncontrolled Hypertension
AstraZeneca's hypertension drug baxdrostat, branded as Baxfendy, has received approval from the U.S. Food and Drug Administration, opening a new treatment pathway for millions of patients whose high blood pressure remains uncontrolled despite existing therapies. The Anglo-Swedish pharmaceutical company...
Business & Industry
EU Advances Critical Medicines Act to Cut Import Reliance
The European Union has moved closer to implementing new measures aimed at protecting the availability of essential medicines and reducing exposure to external supply risks, as lawmakers advanced the Critical Medicines Act framework first introduced in March 2025. The...
Business & Industry
Novartis Expands Radioligand Therapy Manufacturing in US
Swiss pharmaceutical company Novartis has started construction of a new manufacturing facility in Denton, Texas, as part of its previously announced $23 billion investment plan aimed at expanding research and production operations across the United States. The project, expected...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read